Tyra Biosciences Inc (TYRA)

$15.94

-0.49

(-2.98%)

Market is closed - opens 7 PM, 30 May 2024

Insights on Tyra Biosciences Inc

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 64.5% return, outperforming this stock by 46.7%

Performance

  • $15.89
    $16.33
    $15.94
    downward going graph

    0.31%

    Downside

    Day's Volatility :2.66%

    Upside

    2.36%

    downward going graph
  • $10.38
    $20.67
    $15.94
    downward going graph

    34.88%

    Downside

    52 Weeks Volatility :49.78%

    Upside

    22.88%

    downward going graph

Returns

PeriodTyra Biosciences IncIndex (Russel 2000)
3 Months
-17.81%
0.0%
6 Months
48.69%
0.0%
1 Year
17.19%
0.0%
3 Years
-36.81%
-22.0%

Highlights

Market Capitalization
910.0M
Book Value
$7.43
Earnings Per Share (EPS)
-1.69
Wall Street Target Price
25.2
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-16.66%
Return On Equity TTM
-23.63%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
EBITDA
-87.5M
Diluted Eps TTM
-1.69
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-1.71
EPS Estimate Next Year
-2.09
EPS Estimate Current Quarter
-0.45
EPS Estimate Next Quarter
-0.43

Analyst Recommendation

Buy
    83%Buy
    16%Hold
    0
    0%Sell
Based on 12 Wall street analysts offering stock ratings for Tyra Biosciences Inc(by analysts ranked 0 to 5 stars)
Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
10
Hold
2
2
2
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 58.09%

Current $15.94
Target $25.20

Technicals Summary

Sell

Neutral

Buy

Tyra Biosciences Inc is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Tyra Biosciences Inc
Tyra Biosciences Inc
-0.12%
48.69%
17.19%
-36.81%
-36.81%
Moderna, Inc.
Moderna, Inc.
37.25%
93.9%
21.76%
-17.04%
605.99%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
9.04%
20.35%
33.57%
93.38%
216.19%
Novo Nordisk A/s
Novo Nordisk A/s
5.67%
31.45%
67.8%
238.63%
470.19%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
12.79%
27.32%
37.37%
113.13%
168.32%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Tyra Biosciences Inc
Tyra Biosciences Inc
NA
NA
NA
-1.71
-0.24
-0.17
NA
7.43
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.14
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
29.07
29.07
1.46
44.13
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
47.24
47.24
2.36
3.5
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
29.67
29.67
0.53
17.14
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Tyra Biosciences Inc
Tyra Biosciences Inc
Buy
$910.0M
-36.81%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$63.9B
605.99%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$108.5B
216.19%
29.07
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$606.0B
470.19%
47.24
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$117.9B
168.32%
29.67
39.46%

Institutional Holdings

  • RA Capital Management, LLC

    13.78%
  • Boxer Capital LLC

    12.28%
  • Bvf Inc

    8.87%
  • Canaan Partners XI LLC

    8.40%
  • Nextech Invest AG

    7.72%
  • FMR Inc

    5.27%

Company Information

tyra biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.

Organization
Tyra Biosciences Inc
Employees
49
CEO
Dr. Todd Harris Ph.D.
Industry
Miscellaneous

FAQs